153 related articles for article (PubMed ID: 37173831)
1. Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human
Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
J Biomol Struct Dyn; 2024; 42(3):1518-1532. PubMed ID: 37173831
[TBL] [Abstract][Full Text] [Related]
2. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
3. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
[TBL] [Abstract][Full Text] [Related]
4. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
5. Insight into the structural and functional analysis of the impact of missense mutation on cytochrome P450 oxidoreductase.
Kumar R; Jayaraman M; Ramadas K; Chandrasekaran A
J Mol Graph Model; 2020 Nov; 100():107708. PubMed ID: 32805558
[TBL] [Abstract][Full Text] [Related]
6. Computational algorithmic and molecular dynamics study of functional and structural impacts of non-synonymous single nucleotide polymorphisms in human DHFR gene.
Alam MS; Saleh MA; Mozibullah M; Riham AT; Solayman M; Gan SH
Comput Biol Chem; 2021 Dec; 95():107587. PubMed ID: 34710812
[TBL] [Abstract][Full Text] [Related]
7. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.
McCammon KM; Panda SP; Xia C; Kim JJ; Moutinho D; Kranendonk M; Auchus RJ; Lafer EM; Ghosh D; Martasek P; Kar R; Masters BS; Roman LJ
J Biol Chem; 2016 Sep; 291(39):20487-502. PubMed ID: 27496950
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
Bai Y; Li J; Wang X
J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy.
Gong L; Zhang CM; Lv JF; Zhou HH; Fan L
Pharmacogenet Genomics; 2017 Sep; 27(9):337-346. PubMed ID: 28731962
[TBL] [Abstract][Full Text] [Related]
10. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
Velazquez MNR; Parween S; Udhane SS; Pandey AV
Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
[TBL] [Abstract][Full Text] [Related]
11. Identification of the most damaging nsSNPs in the human CFL1 gene and their functional and structural impacts on cofilin-1 protein.
Halder SK; Rafi MO; Shahriar EB; Albogami S; El-Shehawi AM; Daullah SMMU; Himel MK; Emran TB
Gene; 2022 Apr; 819():146206. PubMed ID: 35092861
[TBL] [Abstract][Full Text] [Related]
12. In silico analyses of Wnt1 nsSNPs reveal structurally destabilizing variants, altered interactions with Frizzled receptors and its deregulation in tumorigenesis.
Mondal A; Paul D; Dastidar SG; Saha T; Goswami AM
Sci Rep; 2022 Sep; 12(1):14934. PubMed ID: 36056132
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of human P450 oxidoreductase.
Pandey AV; Sproll P
Front Pharmacol; 2014; 5():103. PubMed ID: 24847272
[TBL] [Abstract][Full Text] [Related]
14. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach.
George Priya Doss C; Nagasundaram N; Chakraborty C; Chen L; Zhu H
Hum Genomics; 2013 Apr; 7(1):10. PubMed ID: 23561625
[TBL] [Abstract][Full Text] [Related]
15. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
16. Computational identification of pathogenic associated nsSNPs and its structural impact in UROD gene: a molecular dynamics approach.
Doss CG; Magesh R
Cell Biochem Biophys; 2014 Nov; 70(2):735-46. PubMed ID: 24777812
[TBL] [Abstract][Full Text] [Related]
17. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive
Hoda A; Berisha B; Bixheku X; Zanchi FB
J Biomol Struct Dyn; 2024 Apr; ():1-17. PubMed ID: 38656135
[TBL] [Abstract][Full Text] [Related]
19. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Agrawal V; Huang N; Miller WL
Pharmacogenet Genomics; 2008 Jul; 18(7):569-76. PubMed ID: 18551037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
